(NASDAQ: AMGN) Amgen's forecast annual revenue growth rate of 8.04% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 4.24%, and it is also forecast to beat the US market's average forecast revenue growth rate of 7.54%.
Amgen's revenue in 2023 is $26,833,000,000.On average, 11 Wall Street analysts forecast AMGN's revenue for 2023 to be $15,049,056,269,392, with the lowest AMGN revenue forecast at $14,971,492,917,939, and the highest AMGN revenue forecast at $15,133,764,247,506. On average, 11 Wall Street analysts forecast AMGN's revenue for 2024 to be $17,335,857,528,957, with the lowest AMGN revenue forecast at $16,474,898,976,047, and the highest AMGN revenue forecast at $18,830,774,058,022.
In 2025, AMGN is forecast to generate $17,809,095,656,646 in revenue, with the lowest revenue forecast at $16,969,424,880,116 and the highest revenue forecast at $19,527,040,671,149.